No significant weaknesses identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| GSHDGoosehead Insurance, Inc | 1.8B | 72.10 | 62.16 | 20.37% | 8.55% | 108.93% | 3.93% | 3.93 |
| ORIOld Republic International Corporation | 10.69B | 43.32 | 13.37 | 13.41% | 9.53% | 12.95% | 11.54% | 0.28 |
| HIGThe Hartford Financial Services Group, Inc. | 36.49B | 130.82 | 12.64 | 8.44% | 12.84% | 19.28% | 15.8% | 0.27 |
| AIZNAssurant, Inc. 5.25% Subordinat | 1.03B | 20.17 | 1.39 | 6.7% | 6.75% | 14.74% | 100% | 0.41 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.77B | 5.9B | 6.26B | 6.26B | 7.46B | 7.17B | 9.34B | 8.08B | 7.26B | 8.23B |
| Revenue Growth % | 0.04% | 0.02% | 0.06% | -0% | 0.19% | -0.04% | 0.3% | -0.13% | -0.1% | 0.13% |
| Medical Costs & Claims | 5.07B | 5.15B | 5.45B | 5.52B | 5.82B | 2.47B | 2.4B | 2.43B | 2.58B | 3.02B |
| Medical Cost Ratio % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 691.6M | 754.2M | 808M | 737.1M | 1.64B | 4.69B | 6.94B | 5.66B | 4.68B | 5.21B |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 0.06% | 0.09% | 0.07% | -0.09% | 1.22% | 1.87% | 0.48% | -0.19% | -0.17% | 0.11% |
| Operating Expenses | 60M | 68.4M | 82.8M | 299.2M | 314.3M | 4B | 5.02B | 4.8B | 3.93B | 4.14B |
| OpEx / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Combined Ratio % | - | - | - | - | - | - | - | - | - | - |
| Operating Income | 631.6M | 685.8M | 725.2M | 437.9M | 1.32B | 688.1M | 1.92B | 857.1M | 747.3M | 1.07B |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 0.04% | 0.09% | 0.06% | -0.4% | 2.02% | -0.48% | 1.79% | -0.55% | -0.13% | 0.43% |
| EBITDA | 673.7M | 736.2M | 788.4M | 480.3M | 1.36B | 732.1M | 1.98B | 924.1M | 817.9M | 1.15B |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | 41.9M | 50.2M | 63M | 42.2M | 40M | 43.7M | 56.2M | 66.7M | 70.5M | 77.3M |
| Non-Operating Income | -42.1M | -50.4M | -63.2M | -42.4M | -40.2M | -44M | -56.4M | -67M | -70.6M | -77.4M |
| Pretax Income | 631.8M | 686M | 725.4M | 438.1M | 1.32B | 688.4M | 1.92B | 857.4M | 747.4M | 1.07B |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 209.6M | 219M | 164.8M | 67.6M | 265.9M | 129.7M | 387.7M | 170.9M | 148.7M | 216.9M |
| Effective Tax Rate % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 422.1M | 466.9M | 560.5M | 370.5M | 1.06B | 558.6M | 1.53B | 686.4M | 598.6M | 852.7M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 0.03% | 0.11% | 0.2% | -0.34% | 1.85% | -0.47% | 1.75% | -0.55% | -0.13% | 0.42% |
| EPS (Diluted) | 1.48 | 1.62 | 1.92 | 1.23 | 3.51 | 1.87 | 5.05 | 2.26 | 2.10 | 3.24 |
| EPS Growth % | 0.03% | 0.09% | 0.19% | -0.36% | 1.85% | -0.47% | 1.7% | -0.55% | -0.07% | 0.54% |
| EPS (Basic) | 1.63 | 1.80 | 2.14 | 1.26 | 3.52 | 1.87 | 5.08 | 2.28 | 2.12 | 3.30 |
| Diluted Shares Outstanding | 296.09M | 296.38M | 299.39M | 301.02M | 301.23M | 298.9M | 303.67M | 303.3M | 285.47M | 263.18M |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 17.11B | 18.59B | 19.4B | 19.33B | 21.08B | 22.82B | 24.98B | 25.16B | 26.5B | 27.84B |
| Asset Growth % | 0.01% | 0.09% | 0.04% | -0% | 0.09% | 0.08% | 0.09% | 0.01% | 0.05% | 0.05% |
| Total Investment Assets | 1.99B | 2.9B | 3.27B | 3.38B | 14.36B | 15.33B | 16.58B | 15.86B | 15.87B | 16.08B |
| Long-Term Investments | 1.99B | 2.9B | 3.27B | 3.38B | 14.33B | 15.3B | 5.3B | 3.22B | 15.83B | 16.04B |
| Short-Term Investments | 0 | 0 | 0 | 0 | 9.28B | 11.25B | 11.24B | 12.61B | 13.17B | 2.84B |
| Total Current Assets | 170.3M | 223.7M | 292.9M | 13.64B | 0 | 0 | 18.12B | 20.22B | 0 | 0 |
| Cash & Equivalents | 9.37B | 9.97B | 10.15B | 9.68B | 78.8M | 118.7M | 158.1M | 81M | 202.8M | 201.9M |
| Receivables | 0 | 0 | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 0 | 0 | 0 | 0 | -14.66B | -17.32B | 3.82B | 5.15B | -21.55B | -12.44B |
| Goodwill & Intangibles | 255.4M | 274M | 297.8M | 490.3M | 0 | 0 | 349M | 356.2M | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 174M | 0 | 0 | 174.5M | 178.1M | 0 | 0 |
| Intangible Assets | 255.4M | 274M | 297.8M | 316.3M | 0 | 0 | 174.5M | 178.1M | 0 | 0 |
| PP&E (Net) | 0 | 3.15B | 2.71B | -771M | 0 | 0 | 4.62B | -677.8M | 0 | 0 |
| Other Assets | -255.4M | -2.9B | -3.27B | 9.58B | -14.33B | -15.3B | -5.3B | 12.61B | -15.83B | -16.04B |
| Total Liabilities | 13.23B | 14.12B | 14.67B | 14.18B | 15.08B | 16.63B | 18.09B | 18.99B | 20.09B | 22.22B |
| Total Debt | 961.7M | 1.53B | 1.45B | 981.3M | 973.9M | 966.4M | 1.59B | 1.6B | 1.59B | 1.59B |
| Net Debt | -8.4B | -8.44B | -8.7B | -8.7B | 895.1M | 847.7M | -9.81B | -11.09B | 1.39B | 1.39B |
| Long-Term Debt | 952.8M | 1.53B | 1.45B | 981.3M | 576.6M | 568.5M | 1.59B | 1.6B | 1.19B | 1.59B |
| Short-Term Debt | 0 | 0 | 0 | 0 | 397.3M | 397.9M | 1.59B | 58.8M | 399.5M | 0 |
| Total Current Liabilities | 452.3M | 10.15B | 10.3B | 10.54B | 0 | 0 | 12.75B | 399M | 0 | 0 |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 292.5M | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | -467.6M | -680.4M | 0 | 0 |
| Other Current Liabilities | -452.3M | -485.4M | -554.2M | -525.4M | -948.2M | -1.07B | 10.76B | -9M | -932.4M | -547.5M |
| Deferred Taxes | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Liabilities | 12.28B | 12.56B | 13.22B | 13.2B | -688.8M | -705.8M | -1.84B | 17.35B | -1.3B | -1.72B |
| Total Equity | 3.88B | 4.47B | 4.73B | 5.15B | 6B | 6.19B | 6.89B | 6.17B | 6.41B | 5.62B |
| Equity Growth % | -0.01% | 0.15% | 0.06% | 0.09% | 0.17% | 0.03% | 0.11% | -0.11% | 0.04% | -0.12% |
| Shareholders Equity | 3.88B | 4.47B | 4.73B | 5.15B | 6B | 6.19B | 6.89B | 6.17B | 6.41B | 5.62B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 2.94B | 3.21B | 3.21B | 3.85B | 4.39B | 4.39B | 5.21B | 5.32B | 5.64B | 5.52B |
| Common Stock | 261.9M | 262.7M | 269.2M | 302.7M | 303.6M | 304.1M | 307.5M | 296.9M | 278.3M | 248.8M |
| Accumulated OCI | 29.2M | 323.6M | 474.2M | -210M | 77.7M | 284M | 78M | -522.7M | -132.4M | -102.4M |
| Return on Equity (ROE) | 0.11% | 0.11% | 0.12% | 0.08% | 0.19% | 0.09% | 0.23% | 0.11% | 0.1% | 0.14% |
| Return on Assets (ROA) | 0.02% | 0.03% | 0.03% | 0.02% | 0.05% | 0.03% | 0.06% | 0.03% | 0.02% | 0.03% |
| Equity / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / Equity | 0.25x | 0.34x | 0.31x | 0.19x | 0.16x | 0.16x | 0.23x | 0.26x | 0.25x | 0.28x |
| Book Value per Share | 13.11 | 15.09 | 15.81 | 17.10 | 19.92 | 20.70 | 22.70 | 20.33 | 22.46 | 21.35 |
| Tangible BV per Share | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 688.2M | 637.3M | 452.8M | 760.5M | 936.2M | 1.19B | 1.31B | 1.17B | 880.4M | 1.23B |
| Operating CF Growth % | 4.8% | -0.07% | -0.29% | 0.68% | 0.23% | 0.27% | 0.11% | -0.11% | -0.25% | 0.4% |
| Operating CF / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 422.1M | 466.9M | 560.5M | 370.5M | 1.06B | 558.6M | 1.53B | 686.4M | 598.6M | 852.7M |
| Depreciation & Amortization | 26.6M | 0 | 27.2M | 27.6M | 26.8M | 26.9M | 27.2M | 28.3M | 33M | 0 |
| Stock-Based Compensation | 2.3M | 3.1M | 3.5M | 3.8M | 3.7M | 2.1M | 3.2M | 9M | 19.5M | 0 |
| Deferred Taxes | 13.4M | 40.6M | 49.5M | -69.5M | 37.2M | -18.3M | 151.4M | -37.3M | 0 | 0 |
| Other Non-Cash Items | -128.7M | -131.6M | -315.1M | 185.9M | -712.5M | 128.9M | -962M | 169.3M | 421.7M | -228.9M |
| Working Capital Changes | 381.4M | 261.4M | 127.2M | 172.7M | 524.6M | 486.8M | 557.6M | 314.9M | -192.4M | 609.6M |
| Cash from Investing | -449.8M | -1.04B | -293.9M | -239.5M | -424.6M | -845.2M | -936.5M | -415M | 25.3M | -7.2M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | -13.1M | -1.2M | 0 | 0 | 0 | 0 | 136.6M |
| Purchase of Investments | -1.92B | -2.74B | -2.45B | -2.17B | -2.65B | -2.65B | -3.36B | -5.42B | -3.48B | -4.53B |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Investing | -12.5M | 9.2M | -24.3M | -31.9M | -28M | -41.8M | -47.1M | -12.3M | 200K | -4.5M |
| Cash from Financing | -215.2M | 385M | -178.5M | -546.5M | -533.1M | -300M | -335.7M | -832.7M | -783.2M | -1.23B |
| Dividends Paid | -191.3M | -193.8M | -198.8M | -498.8M | -538.7M | -250.1M | -1.02B | -579.7M | -275.5M | -271.9M |
| Share Repurchases | -34M | 0 | 0 | 0 | 0 | 0 | 0 | -281.2M | -535.3M | -942.2M |
| Stock Issued | 12M | 8.4M | 17.8M | 13.1M | 13.8M | 6.7M | 60M | 26.6M | 31.1M | 2M |
| Debt Issuance (Net) | -1000K | 1000K | -1000K | -1000K | -1000K | -1000K | 1000K | 0 | -1000K | -1000K |
| Other Financing | 1.4M | -2.9M | 6.4M | -6.1M | 200K | 2M | 2.7M | 1.6M | 1.8M | -10.7M |
| Net Change in Cash | 23.1M | -14.1M | -19.8M | -25.6M | -21.5M | 39.9M | 39.4M | -77.1M | 121.8M | -900K |
| Exchange Rate Effect | -100K | 0 | -200K | -100K | 0 | 100K | -100K | 0 | -700K | -200K |
| Cash at Beginning | 136.7M | 159.8M | 145.7M | 125.9M | 100.3M | 78.8M | 118.7M | 158.1M | 81M | 202.8M |
| Cash at End | 159.8M | 145.7M | 125.9M | 100.3M | 78.8M | 118.7M | 158.1M | 81M | 202.8M | 201.9M |
| Free Cash Flow | 688.2M | 637.3M | 452.8M | 760.5M | 936.2M | 1.19B | 1.31B | 1.17B | 880.4M | 1.23B |
| FCF Growth % | 4.8% | -0.07% | -0.29% | 0.68% | 0.23% | 0.27% | 0.11% | -0.11% | -0.25% | 0.4% |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - |
| FCF per Share | 2.32 | 2.15 | 1.51 | 2.53 | 3.11 | 3.96 | 4.32 | 3.86 | 3.08 | 4.69 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 89.05% | 88.38% | 88.42% | 93% | 82.28% | 90.4% | 79.43% | 89.4% | 89.7% | 87.01% |
| Medical Cost Ratio | 88.01% | 87.22% | 87.1% | 88.22% | 78.06% | 34.51% | 25.67% | 30.03% | 35.55% | 36.74% |
| Return on Equity (ROE) | 10.82% | 11.18% | 12.18% | 7.5% | 18.96% | 9.17% | 23.46% | 10.51% | 9.52% | 14.18% |
| Return on Assets (ROA) | 2.48% | 2.62% | 2.95% | 1.91% | 5.23% | 2.55% | 6.42% | 2.74% | 2.32% | 3.14% |
| Equity / Assets | 22.68% | 24.05% | 24.39% | 26.63% | 28.47% | 27.12% | 27.59% | 24.51% | 24.19% | 20.18% |
| Book Value / Share | 13.11 | 15.09 | 15.81 | 17.1 | 19.92 | 20.7 | 22.7 | 20.33 | 22.46 | 21.35 |
| Debt / Equity | 0.25x | 0.34x | 0.31x | 0.19x | 0.16x | 0.16x | 0.23x | 0.26x | 0.25x | 0.28x |
| Revenue Growth | 4.26% | 2.33% | 6.15% | -0.07% | 19.2% | -3.95% | 30.36% | -13.47% | -10.21% | 13.41% |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| General Insurance | - | - | - | - | - | - | - | - | 4.12B | 4.68B |
| General Insurance Growth | - | - | - | - | - | - | - | - | - | 13.54% |
| Title Insurance Group | - | - | - | - | - | - | 4.45B | 3.88B | 2.3B | 2.33B |
| Title Insurance Group Growth | - | - | - | - | - | - | - | -12.73% | -40.74% | 1.46% |
| Corporate & Other | - | - | - | - | - | - | - | - | 9.1M | 14.6M |
| Corporate & Other Growth | - | - | - | - | - | - | - | - | - | 60.44% |
| RFIG Run-off Business | - | - | - | 96.1M | 76.8M | 60.4M | 44.1M | 30M | 16.4M | - |
| RFIG Run-off Business Growth | - | - | - | - | -20.08% | -21.35% | -26.99% | -31.97% | -45.33% | - |
| Reinsurance Recoverable | - | - | - | - | - | - | - | - | - | - |
| Reinsurance Recoverable Growth | - | - | - | - | - | - | - | - | - | - |
| Total of major segments | 5.64B | 5.79B | 6B | 6.21B | 6.53B | 7.27B | 8.54B | 8.23B | - | - |
| Total of major segments Growth | - | 2.72% | 3.61% | 3.49% | 5.12% | 11.30% | 17.47% | -3.60% | - | - |
| General Insurance Group | 3.31B | 3.35B | 3.53B | 3.74B | 3.92B | 3.88B | 4.04B | 4.32B | - | - |
| General Insurance Group Growth | - | 1.25% | 5.27% | 5.88% | 4.85% | -1.12% | 4.27% | 6.76% | - | - |
| Others | 118.1M | 130.4M | 170.3M | 169.1M | 170M | 149.6M | 166.6M | 195.5M | - | - |
| Others Growth | - | 10.41% | 30.60% | -0.70% | 0.53% | -12.00% | 11.36% | 17.35% | - | - |
| Title Insurance Product Line | - | - | - | 2.38B | 2.53B | 3.33B | - | - | - | - |
| Title Insurance Product Line Growth | - | - | - | - | 6.56% | 31.53% | - | - | - | - |
| Intersegment Eliminations | -82.3M | -94.9M | -120.1M | -122.7M | -121.4M | -108.2M | - | - | - | - |
| Intersegment Eliminations Growth | - | -15.31% | -26.55% | -2.16% | 1.06% | 10.87% | - | - | - | - |
Old Republic International Corporation (ORI) has a price-to-earnings (P/E) ratio of 13.4x. This may indicate the stock is undervalued or faces growth challenges.
Old Republic International Corporation (ORI) grew revenue by 13.4% over the past year. This is steady growth.
Yes, Old Republic International Corporation (ORI) is profitable, generating $834.0M in net income for fiscal year 2024 (10.4% net margin).
Yes, Old Republic International Corporation (ORI) pays a dividend with a yield of 2.38%. This makes it attractive for income-focused investors.
Old Republic International Corporation (ORI) has a return on equity (ROE) of 14.2%. This is reasonable for most industries.
Old Republic International Corporation (ORI) has a combined ratio of 87.0%. A ratio below 100% indicates underwriting profitability.